Crinetics Pharmaceuticals IncNASDAQ:CRNX
- LAST PRICE43.8200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots40.0000/ 1
- Ask / Lots69.6700/ 1
- Open / Previous Close0.0000 / 43.8200
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRNX |
|---|---|---|
| 09:32 ET | 11850 | 43.16 |
| 09:34 ET | 500 | 43.21 |
| 09:36 ET | 200 | 43.33 |
| 09:39 ET | 200 | 43.32 |
| 09:41 ET | 521 | 43.62 |
| 09:43 ET | 1656 | 43.65 |
| 09:45 ET | 200 | 43.765 |
| 09:48 ET | 100 | 43.69 |
| 09:50 ET | 702 | 43.87 |
| 09:52 ET | 1200 | 43.885 |
| 09:54 ET | 2000 | 43.68 |
| 09:56 ET | 1300 | 43.78 |
| 09:57 ET | 100 | 43.68 |
| 09:59 ET | 900 | 43.79 |
| 10:01 ET | 523 | 43.8136 |
| 10:03 ET | 1000 | 43.63 |
| 10:06 ET | 1300 | 43.71 |
| 10:08 ET | 1010 | 43.68 |
| 10:10 ET | 800 | 43.85 |
| 10:12 ET | 1000 | 43.765 |
| 10:14 ET | 806 | 43.695 |
| 10:15 ET | 600 | 43.63 |
| 10:17 ET | 424 | 43.75 |
| 10:19 ET | 2200 | 43.73 |
| 10:24 ET | 800 | 43.775 |
| 10:26 ET | 6018 | 43.87 |
| 10:28 ET | 400 | 43.81 |
| 10:30 ET | 800 | 43.87 |
| 10:32 ET | 3706 | 43.665 |
| 10:33 ET | 4118 | 43.645 |
| 10:35 ET | 2300 | 43.51 |
| 10:37 ET | 946 | 43.45 |
| 10:39 ET | 866 | 43.485 |
| 10:42 ET | 600 | 43.435 |
| 10:44 ET | 1622 | 43.41 |
| 10:46 ET | 1000 | 43.54 |
| 10:48 ET | 1989 | 43.81 |
| 10:50 ET | 706 | 43.715 |
| 10:51 ET | 200 | 43.715 |
| 10:53 ET | 3439 | 43.63 |
| 10:57 ET | 2060 | 43.69 |
| 11:00 ET | 1400 | 43.735 |
| 11:02 ET | 1100 | 43.74 |
| 11:04 ET | 1300 | 43.93 |
| 11:06 ET | 400 | 43.94 |
| 11:08 ET | 2808 | 43.89 |
| 11:11 ET | 700 | 43.855 |
| 11:13 ET | 5233 | 43.76 |
| 11:15 ET | 1110 | 43.69 |
| 11:18 ET | 708 | 43.66 |
| 11:20 ET | 2100 | 43.8 |
| 11:22 ET | 1077 | 43.865 |
| 11:24 ET | 100 | 43.84 |
| 11:26 ET | 1153 | 43.89 |
| 11:29 ET | 200 | 43.91 |
| 11:31 ET | 700 | 43.9 |
| 11:33 ET | 2210 | 43.84 |
| 11:36 ET | 200 | 43.88 |
| 11:38 ET | 1000 | 43.835 |
| 11:40 ET | 1100 | 43.79 |
| 11:42 ET | 1100 | 43.76 |
| 11:44 ET | 2200 | 43.73 |
| 11:45 ET | 1500 | 43.75 |
| 11:47 ET | 448 | 43.8173 |
| 11:49 ET | 1936 | 43.72 |
| 11:54 ET | 500 | 43.67 |
| 11:56 ET | 1235 | 43.685 |
| 11:58 ET | 700 | 43.69 |
| 12:00 ET | 1900 | 43.78 |
| 12:02 ET | 700 | 43.68 |
| 12:03 ET | 908 | 43.61 |
| 12:05 ET | 421 | 43.79 |
| 12:07 ET | 100 | 43.805 |
| 12:09 ET | 500 | 43.81 |
| 12:12 ET | 916 | 43.745 |
| 12:14 ET | 100 | 43.7 |
| 12:20 ET | 800 | 43.82 |
| 12:21 ET | 641 | 43.82 |
| 12:23 ET | 1783 | 43.79 |
| 12:25 ET | 300 | 43.75 |
| 12:27 ET | 100 | 43.72 |
| 12:30 ET | 300 | 43.72 |
| 12:32 ET | 1700 | 43.725 |
| 12:34 ET | 100 | 43.735 |
| 12:36 ET | 1298 | 43.85 |
| 12:38 ET | 800 | 43.885 |
| 12:39 ET | 1400 | 43.74 |
| 12:41 ET | 300 | 43.785 |
| 12:43 ET | 100 | 43.72 |
| 12:45 ET | 1125 | 43.81 |
| 12:48 ET | 815 | 43.825 |
| 12:50 ET | 600 | 43.855 |
| 12:52 ET | 1273 | 43.965 |
| 12:54 ET | 100 | 43.995 |
| 12:56 ET | 600 | 44.03 |
| 12:57 ET | 884 | 44.08 |
| 12:59 ET | 200 | 44.085 |
| 01:01 ET | 600 | 44.08 |
| 01:03 ET | 1000 | 44.1475 |
| 01:06 ET | 500 | 44.17 |
| 01:08 ET | 800 | 44.245 |
| 01:10 ET | 3827 | 44.1698 |
| 01:12 ET | 400 | 44.14 |
| 01:14 ET | 1461 | 44.13 |
| 01:17 ET | 446 | 44.2 |
| 01:19 ET | 200 | 44.27 |
| 01:21 ET | 200 | 44.221 |
| 01:24 ET | 236 | 44.32 |
| 01:26 ET | 1700 | 44.36 |
| 01:28 ET | 1500 | 44.4332 |
| 01:30 ET | 3576 | 44.37 |
| 01:32 ET | 900 | 44.15 |
| 01:33 ET | 800 | 44.21 |
| 01:35 ET | 1101 | 44.22 |
| 01:37 ET | 250 | 44.22 |
| 01:39 ET | 100 | 44.25 |
| 01:42 ET | 871 | 44.27 |
| 01:44 ET | 900 | 44.31 |
| 01:48 ET | 300 | 44.365 |
| 01:50 ET | 700 | 44.465 |
| 01:51 ET | 788 | 44.49 |
| 01:53 ET | 200 | 44.47 |
| 01:55 ET | 200 | 44.515 |
| 02:00 ET | 697 | 44.475 |
| 02:02 ET | 3247 | 44.425 |
| 02:04 ET | 869 | 44.3 |
| 02:06 ET | 300 | 44.26 |
| 02:08 ET | 200 | 44.24 |
| 02:09 ET | 1000 | 44.33 |
| 02:11 ET | 300 | 44.315 |
| 02:13 ET | 300 | 44.25 |
| 02:15 ET | 900 | 44.32 |
| 02:18 ET | 1100 | 44.25 |
| 02:20 ET | 300 | 44.25 |
| 02:22 ET | 300 | 44.28 |
| 02:24 ET | 1607 | 44.305 |
| 02:26 ET | 400 | 44.32 |
| 02:27 ET | 300 | 44.29 |
| 02:29 ET | 2215 | 44.25 |
| 02:31 ET | 1100 | 44.36 |
| 02:33 ET | 300 | 44.35 |
| 02:36 ET | 842 | 44.42 |
| 02:38 ET | 1700 | 44.34 |
| 02:40 ET | 100 | 44.37 |
| 02:42 ET | 1506 | 44.38 |
| 02:45 ET | 1700 | 44.29 |
| 02:47 ET | 300 | 44.29 |
| 02:49 ET | 1500 | 44.22 |
| 02:51 ET | 1950 | 44.25 |
| 02:54 ET | 1100 | 44.23 |
| 02:56 ET | 700 | 44.23 |
| 02:58 ET | 900 | 44.22 |
| 03:00 ET | 500 | 44.25 |
| 03:02 ET | 1400 | 44.2 |
| 03:03 ET | 300 | 44.225 |
| 03:05 ET | 706 | 44.2 |
| 03:07 ET | 3100 | 44.04 |
| 03:09 ET | 300 | 43.95 |
| 03:12 ET | 900 | 44.03 |
| 03:14 ET | 771 | 44.02 |
| 03:16 ET | 905 | 43.99 |
| 03:18 ET | 2684 | 43.92 |
| 03:20 ET | 100 | 44 |
| 03:21 ET | 1192 | 44.015 |
| 03:23 ET | 3660 | 43.975 |
| 03:25 ET | 600 | 43.985 |
| 03:27 ET | 2200 | 43.94 |
| 03:30 ET | 1400 | 43.9 |
| 03:32 ET | 1135 | 43.88 |
| 03:34 ET | 1732 | 43.9 |
| 03:36 ET | 2412 | 43.86 |
| 03:38 ET | 1530 | 43.84 |
| 03:39 ET | 900 | 44.05 |
| 03:41 ET | 1424 | 44.015 |
| 03:43 ET | 1316 | 44.025 |
| 03:45 ET | 3617 | 44.01 |
| 03:48 ET | 3000 | 44.02 |
| 03:50 ET | 2295 | 44.105 |
| 03:52 ET | 4882 | 44.05 |
| 03:54 ET | 5235 | 43.98 |
| 03:56 ET | 3729 | 43.91 |
| 03:57 ET | 7248 | 43.885 |
| 03:59 ET | 14978 | 43.82 |
Apr 11, 2024
Crinetics Pharmaceuticals Announces April 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:05PM ET on Thursday Apr 11, 2024 by Dow Jones
4:05PM ET on Thursday Apr 11, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Crinetics Pharmaceuticals Inc | 3.5B | -11.9x | --- |
SpringWorks Therapeutics Inc | 3.5B | -9.1x | --- |
Biohaven Ltd | 3.4B | -6.8x | --- |
Iovance Biotherapeutics Inc | 3.3B | -6.2x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Xenon Pharmaceuticals Inc | 3.1B | -14.9x | --- |
Company Information
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Contact Information
- Headquarters
- 10222 Barnes Canyon Rd Bldg 2SAN DIEGO, CA, United States 92121-2711
- Phone
- 858-450-6464
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Wendell Wierenga
- Co-Founder, Director
- R. Scott Struthers
- Co-Founder, Chief Scientific Officer
- Stephen Betz
- Chief Financial Officer
- Marc Wilson
- Chief Operating Officer
- Jeff Knight
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.5B |
|---|---|
Revenue (TTM) | $4.0M |
Shares Outstanding | 78.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.63 |
EPS | $-3.70 |
Book Value | $7.91 |
P/E Ratio | -11.9x |
Price/Sales (TTM) | 859.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -5,547.17% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
